Breakthrough drug helps severe asthma patients ditch harmful steroids

NCT ID NCT05274815

Summary

This study tested whether a drug called tezepelumab, given as a shot, could help adults with severe asthma safely reduce or stop their daily oral steroid pills. It involved 305 participants who were already taking high doses of inhaled medicine plus daily steroid pills. The main goal was to see if people could lower their steroid dose or stop it completely without their asthma getting worse over one year.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Newport Beach, California, 92663, United States

  • Research Site

    Newark, Delaware, 19713, United States

  • Research Site

    Loxahatchee Groves, Florida, 33470, United States

  • Research Site

    Ann Arbor, Michigan, 48109, United States

  • Research Site

    Toms River, New Jersey, 08755, United States

  • Research Site

    The Bronx, New York, 10467, United States

  • Research Site

    DuBois, Pennsylvania, 15801, United States

  • Research Site

    Buenos Aires, C1121ABE, Argentina

  • Research Site

    CABA, 1426, Argentina

  • Research Site

    CABA, C1012AAR, Argentina

  • Research Site

    Mendoza, M5500GHB, Argentina

  • Research Site

    Monte Grande, 1842, Argentina

  • Research Site

    Pilar, 1629, Argentina

  • Research Site

    Quilmes, B1878FNR, Argentina

  • Research Site

    Ranelagh, 1886, Argentina

  • Research Site

    Rosario, 2000, Argentina

  • Research Site

    San Fernando, B1646EBJ, Argentina

  • Research Site

    San Juan Bautista, 1888, Argentina

  • Research Site

    San Miguel de Tucumán, 4000, Argentina

  • Research Site

    Brussels (Woluwé-St-Lambert), 1200, Belgium

  • Research Site

    Erpent, 5101, Belgium

  • Research Site

    Ghent, 9000, Belgium

  • Research Site

    Liège, 4000, Belgium

  • Research Site

    Haskovo, 6305, Bulgaria

  • Research Site

    Razgrad, 7200, Bulgaria

  • Research Site

    Sofia, 1142, Bulgaria

  • Research Site

    Sofia, 1431, Bulgaria

  • Research Site

    Sofia, 5000, Bulgaria

  • Research Site

    Velika Tarnovo, 5250, Bulgaria

  • Research Site

    Antony, 92160, France

  • Research Site

    Bordeaux, 33076, France

  • Research Site

    Brest, 29609, France

  • Research Site

    Lyon, 69004, France

  • Research Site

    Marseille, 13915, France

  • Research Site

    Montpellier, France

  • Research Site

    Nantes, 44000, France

  • Research Site

    Nice, 06000, France

  • Research Site

    Berlin, 12203, Germany

  • Research Site

    Darmstadt, 64283, Germany

  • Research Site

    Fürstenwalde, 15517, Germany

  • Research Site

    Mainz, 55128, Germany

  • Research Site

    Reinfeld (Holstein), 23858, Germany

  • Research Site

    Daugavpils, LV-5410, Latvia

  • Research Site

    Daugavpils, LV-5417, Latvia

  • Research Site

    Jūrmala, LV-2015, Latvia

  • Research Site

    Riga, LV-1011, Latvia

  • Research Site

    Riga, LV1002, Latvia

  • Research Site

    Riga, LV1010, Latvia

  • Research Site

    Valmiera, LV-4201, Latvia

  • Research Site

    Chihuahua City, 31000, Mexico

  • Research Site

    Chihuahua City, 31200, Mexico

  • Research Site

    Guadalajara, 44100, Mexico

  • Research Site

    Monterrey, 64360, Mexico

  • Research Site

    Bychawa, 23100, Poland

  • Research Site

    Chmielnik, 26-020, Poland

  • Research Site

    Gdansk, 80-952, Poland

  • Research Site

    Krakow, 31-011, Poland

  • Research Site

    Lodz, 92-213, Poland

  • Research Site

    Ostrowiec Świętokrzyski, 27-400, Poland

  • Research Site

    Sosnowiec, 41-200, Poland

  • Research Site

    Wroclaw, 50-044, Poland

  • Research Site

    Wroclaw, 53-301, Poland

  • Research Site

    Wroclaw, 54-239, Poland

  • Research Site

    Badalona, 08916, Spain

  • Research Site

    Barcelona, 8035, Spain

  • Research Site

    Madrid, 28041, Spain

  • Research Site

    Oviedo, 33011, Spain

  • Research Site

    Santa Cruz de Tenerife, 38010, Spain

  • Research Site

    Santander, 39008, Spain

  • Research Site

    Seville, 41009, Spain

  • Research Site

    Belfast, BT97AB, United Kingdom

  • Research Site

    Bradford, BD9 6RJ, United Kingdom

  • Research Site

    LE3 9QP, United Kingdom

  • Research Site

    London, SE1 7EH, United Kingdom

  • Research Site

    London, SW3 6HP, United Kingdom

  • Research Site

    Nottingham, NG5 1PB, United Kingdom

  • Research Site

    Portsmouth, PO6 3LY, United Kingdom

Conditions

Explore the condition pages connected to this study.